Questions to Ask Before an Online GLP-1 Medication Review

Clarify which product is being discussed

Semaglutide and tirzepatide are active ingredients used in FDA-approved products, but the name of an ingredient does not make every version FDA-approved. Ask for the exact product name and whether the proposed preparation is FDA-approved or compounded.

FDA warns that unapproved versions do not undergo the agency's premarket review for safety, effectiveness, and quality. A compounded product should not be described as the same as an FDA-approved drug.

Confirm the screening is individualized

FDA lists the absence of screening and a prescription from a licensed doctor as a telehealth warning sign. The review should address current medicines and supplements, relevant health history, allergies, and prior reactions.

Completing a form does not guarantee a prescription. A clinician may request more information or determine that treatment is not appropriate.

Identify the dispensing pharmacy

• What is the pharmacy's name and contact information?
• Is the pharmacy licensed in the state where it serves me?
• Who can answer a question about the product, label, or instructions?
• What should I do if the product does not match what was described?

Make the instructions specific

FDA has received reports involving dosing errors with compounded injectable semaglutide products and concerns about doses beyond approved labeling. This guide does not provide dosing instructions; the point is to obtain clear directions for the exact product from the responsible clinician and pharmacy.

Ask how follow-up questions, suspected side effects, and product-quality concerns should be reported. Call 911 for a medical emergency.